[go: up one dir, main page]

NI200900081U - Anticuerpos agonistas de trkb y sus usos. - Google Patents

Anticuerpos agonistas de trkb y sus usos.

Info

Publication number
NI200900081U
NI200900081U NI200900081U NI200900081U NI200900081U NI 200900081 U NI200900081 U NI 200900081U NI 200900081 U NI200900081 U NI 200900081U NI 200900081 U NI200900081 U NI 200900081U NI 200900081 U NI200900081 U NI 200900081U
Authority
NI
Nicaragua
Prior art keywords
agonist antibodies
trkb agonist
trkb
antibodies
methods
Prior art date
Application number
NI200900081U
Other languages
English (en)
Inventor
Wang Yan
Bruce Cohen Steven
Nasoff Marc
Original Assignee
Irm Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irm Llc filed Critical Irm Llc
Publication of NI200900081U publication Critical patent/NI200900081U/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención brinda anticuerpos antagonistas de TrkB y métodos para su uso.
NI200900081U 2006-11-09 2009-05-08 Anticuerpos agonistas de trkb y sus usos. NI200900081U (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85816906P 2006-11-09 2006-11-09

Publications (1)

Publication Number Publication Date
NI200900081U true NI200900081U (es) 2010-03-16

Family

ID=39365312

Family Applications (1)

Application Number Title Priority Date Filing Date
NI200900081U NI200900081U (es) 2006-11-09 2009-05-08 Anticuerpos agonistas de trkb y sus usos.

Country Status (27)

Country Link
US (1) US20100150914A1 (es)
EP (1) EP2087007A2 (es)
JP (1) JP2010509354A (es)
KR (1) KR20090088896A (es)
CN (1) CN101573381A (es)
AR (1) AR063640A1 (es)
AU (1) AU2007316418A1 (es)
BR (1) BRPI0719000A2 (es)
CA (1) CA2669205A1 (es)
CL (1) CL2007003236A1 (es)
CO (1) CO6180432A2 (es)
CR (1) CR10779A (es)
DO (1) DOP2009000102A (es)
EA (1) EA200970469A1 (es)
EC (1) ECSP099392A (es)
IL (1) IL198468A0 (es)
MA (1) MA30922B1 (es)
MX (1) MX2009004881A (es)
NI (1) NI200900081U (es)
NO (1) NO20092217L (es)
PE (1) PE20081168A1 (es)
RU (1) RU2009121641A (es)
SM (1) SMAP200900040A (es)
TN (1) TN2009000181A1 (es)
TW (1) TW200829270A (es)
WO (1) WO2008058127A2 (es)
ZA (1) ZA200902943B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011501760A (ja) * 2007-10-23 2011-01-13 ノバルティス アーゲー 呼吸器疾患の処置のためのｔｒｋｂ抗体の使用
CN102015769B (zh) * 2008-01-17 2014-12-10 Irm责任有限公司 改进的抗-trkb抗体
WO2010106187A2 (en) * 2009-03-20 2010-09-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Inhibitors of cathepsin s for prevention or treatment of obesity-associated disorders
GB2491106A (en) * 2011-05-18 2012-11-28 Univ Basel Antibodies against tropomyosin-related kinase B receptors
JP2015500823A (ja) * 2011-12-09 2015-01-08 ノヴォ ノルディスク アー／エス Ｇｌｐ−１アゴニスト
CN102901815B (zh) * 2012-11-05 2014-10-22 武汉远征世纪制药有限公司 一种检测TrkB受体816/817位酪氨酸位点活性的ELISA试剂盒及其使用方法
CN102944674B (zh) * 2012-11-05 2014-10-22 武汉远征世纪制药有限公司 一种检测TrkB受体pan-Tyr位点活性的ELISA试剂盒及其使用方法
EP3143043B1 (en) 2014-05-16 2022-12-14 Pfizer Inc. Bispecific antibodies with engineered ch1-cl interfaces
CN104524568B (zh) * 2015-01-08 2018-04-20 中国人民解放军第二军医大学 一种治疗肥胖症的药物组合物及其应用
WO2017019907A1 (en) 2015-07-28 2017-02-02 Otonomy, Inc. Trkb or trkc agonist compositions and methods for the treatment of otic conditions
CA3005491A1 (en) 2015-11-17 2017-05-26 Glaxosmithkline Intellectual Property Development Limited Binding agonists for treatment of neurological and other disorders
US9914781B1 (en) 2016-11-08 2018-03-13 Glaxosmithkline Intellectual Property Development Limited Binding agonist for treatment of neurological and other disorders
WO2018195008A1 (en) * 2017-04-21 2018-10-25 Mellitus, Llc Methods and antibodies for diabetes-related applications
US10793634B2 (en) * 2017-06-09 2020-10-06 Boehringer Ingelheim International Gmbh Anti-TrkB antibodies
MX2020003550A (es) 2017-11-30 2020-08-03 Regeneron Pharma Anticuerpos monoclonales anti-trkb y metodos de uso.
CN112272677B (zh) * 2018-02-26 2024-10-29 米纳瓦生物技术公司 使用抗muc1＊抗体的诊断方法
CN110818797B (zh) * 2018-08-09 2022-11-04 东莞市朋志生物科技有限公司 一种抗人ca153蛋白的重组抗体
AR123862A1 (es) 2020-10-21 2023-01-18 Boehringer Ingelheim Int Moléculas de unión biespecíficas anti-vegf y anti-trkb para el tratamiento de enfermedades oculares
WO2023125485A1 (en) * 2021-12-28 2023-07-06 4B Technologies (Beijing) Co., Limited TrkB ANTIBODY AND APPLICATION THEREOF

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997891A1 (en) 1988-09-02 2008-12-03 Dyax Corporation Generation and selection of recombinant varied binding proteins
WO1991010737A1 (en) 1990-01-11 1991-07-25 Molecular Affinities Corporation Production of antibodies using gene libraries
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DE69233750D1 (de) 1991-04-10 2009-01-02 Scripps Research Inst Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
ATE408012T1 (de) 1991-12-02 2008-09-15 Medical Res Council Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
WO1995015982A2 (en) 1993-12-08 1995-06-15 Genzyme Corporation Process for generating specific antibodies
DK1231268T3 (da) 1994-01-31 2005-11-21 Univ Boston Polyklonale antistofbiblioteker
US5601820A (en) * 1994-07-07 1997-02-11 Children's Hospital Of Philadelphia Compositions and methods of making and using human full length TRK-B
KR20080032070A (ko) * 2005-06-06 2008-04-14 와이어쓰 항-ＴｒｋＢ 모노클로날 항체 및 이의 용도
CA2637707A1 (en) * 2006-02-02 2007-08-09 Rinat Neuroscience Corporation Methods for treating obesity by administering a trkb antagonist
CN101400367A (zh) * 2006-02-02 2009-04-01 瑞纳神经科学公司 施用trkb激动剂治疗不希望的重量减轻或进食障碍的方法

Also Published As

Publication number Publication date
RU2009121641A (ru) 2010-12-20
ECSP099392A (es) 2009-07-31
CR10779A (es) 2009-07-03
MX2009004881A (es) 2009-05-21
PE20081168A1 (es) 2008-09-22
CO6180432A2 (es) 2010-07-19
NO20092217L (no) 2009-06-09
IL198468A0 (en) 2011-08-01
KR20090088896A (ko) 2009-08-20
DOP2009000102A (es) 2010-10-31
TW200829270A (en) 2008-07-16
JP2010509354A (ja) 2010-03-25
AR063640A1 (es) 2009-02-04
SMAP200900040A (it) 2010-01-19
US20100150914A1 (en) 2010-06-17
MA30922B1 (fr) 2009-11-02
WO2008058127A2 (en) 2008-05-15
CN101573381A (zh) 2009-11-04
WO2008058127A3 (en) 2008-10-02
TN2009000181A1 (en) 2010-10-18
EP2087007A2 (en) 2009-08-12
CL2007003236A1 (es) 2008-06-13
AU2007316418A1 (en) 2008-05-15
CA2669205A1 (en) 2008-05-15
ZA200902943B (en) 2010-05-26
BRPI0719000A2 (pt) 2013-12-10
EA200970469A1 (ru) 2010-04-30
WO2008058127A9 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
NI200900081U (es) Anticuerpos agonistas de trkb y sus usos.
ECSP099027A (es) Anticuerpos anti-dll4 y métodos que los usan
ECSP099785A (es) Anticuerpos anti-notch1 nrr y sus métodos de uso
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
ECSP13013022A (es) Agonistas de fgfr1 y sus métodos de uso
PA8718601A1 (es) Anticuerpos anti-5t4 y sus usos
CO6720984A2 (es) Anticuerpos anti-mesotelina e inmunoconjugados
CU24058B1 (es) Antagonistas de pcsk9
ECSP088543A (es) Anticuerpos anti-ox40l y métodos que los utilizan
SV2011003834A (es) Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0906478A2 (pt) anticorpo anti-nr10 e uso do mesmo
ECSP11011344A (es) Nuevos anticuerpos anti-?5?1 y sus usos
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
BRPI0915928A2 (pt) composições e métodos de uso para anticorpos terapêuticos
ATE496051T1 (de) Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten
BRPI0811635A2 (pt) Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
BRPI0820407A2 (pt) Uso de anticorpos anti-cd40
CR20140212A (es) Anticuerpos anti-htra1 y métodos de uso
CR10481A (es) Equipo, sistemas y metodos para confirmar el uso de un dispositivo oral
DE602007004999D1 (de) 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen-derivate als orexinrezeptor-antagonisten
ECSP088743A (es) Anticuerpos para egfl7 y métodos para su uso
AR059096A1 (es) Anticuerpos anti- efrina -b2 y metodos que usan estos
BRPI0909828A2 (pt) corantes dispersos de azopiridona, sua preparação e uso